DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
This Quarter Return
+8.73%
1 Year Return
-10.85%
3 Year Return
+35.19%
5 Year Return
+71.7%
10 Year Return
–
AUM
$1.25B
AUM Growth
+$1.25B
(+6.3%)
Cap. Flow
+$34.1M
Cap. Flow
% of AUM
2.74%
Top 10 Holdings %
Top 10 Hldgs %
26.05%
Holding
311
New
17
Increased
128
Reduced
145
Closed
4
Top Buys
| 1 |
Vanguard Emerging Markets Government Bond ETF
VWOB
|
$2.87M |
| 2 |
Costco
COST
|
$2.11M |
| 3 |
Qualcomm
QCOM
|
$1.05M |
| 4 |
Microsoft
MSFT
|
$846K |
| 5 |
Vanguard Total International Bond ETF
BNDX
|
$733K |
Top Sells
| 1 |
DexCom
DXCM
|
$14M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$4.74M |
| 3 |
Amazon
AMZN
|
$1.99M |
| 4 |
Apple
AAPL
|
$1.93M |
| 5 |
MZTI
The Marzetti Company Common Stock
MZTI
|
$1.02M |
Sector Composition
| 1 | Technology | 17.31% |
| 2 | Healthcare | 12.84% |
| 3 | Consumer Staples | 10.16% |
| 4 | Financials | 10.08% |
| 5 | Consumer Discretionary | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Fortress Biotech
FBIO
$87.8M
| $81K | 0.01% |
1,333
| – | – |
|
|
BMY.RT
302
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $58K | ﹤0.01% |
25,979
-2,145
| -8% | -$4.79K |
|
303
BioCryst Pharmaceuticals
BCRX
$1.74B
| $55K | ﹤0.01% |
16,000
+5,000
| +45% | +$17.2K |
|
|
ADMS
304
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $54K | ﹤0.01% |
13,000
| – | – |
|
|
YELL
305
DELISTED
Yellow Corporation Common Stock
YELL
| $39K | ﹤0.01% |
+10,000
| New | +$39K |
|
|
PANA.WS
306
DELISTED
Panacea Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class
PANA.WS
| $26K | ﹤0.01% |
+11,063
| New | +$26K |
|
|
RGLS
307
DELISTED
Regulus Therapeutics
RGLS
| $6K | ﹤0.01% |
1,200
| – | – |
|
308
Actinium Pharmaceuticals
ATNM
$53.3M
| – | – |
-762
| Closed | -$8K |
|
309
EOG Resources
EOG
$65.8B
| – | – |
-4,722
| Closed | -$239K |
|
310
First Trust Enhanced Short Maturity ETF
FTSM
$6.16B
| – | – |
-9,663
| Closed | -$580K |
|
311
iShares S&P 500 Value ETF
IVE
$40.9B
| – | – |
-1,850
| Closed | -$200K |
|